Skip to content
10-Q

Quarterly Report

Mangoceuticals, Inc. MGRX

0001493152-25-023640

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 13.91M sh
Shares Diluted Q3 2025 · Sep 30, 2025 11.52M sh
Shares Diluted Q3 2025 · Sep 30, 2025 8.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 2.01M sh
Shares Diluted Q3 2025 · Sep 30, 2024 1.77M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$4.77M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$3.73M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $481.28K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $58.65K
Stockholders Equity Q3 2025 · Sep 30, 2025 $15.73M
Stockholders Equity Q3 2025 · Dec 31, 2024 $13.95M
Current Liabilities Q3 2025 · Sep 30, 2025 $804.28K
Current Liabilities Q3 2025 · Dec 31, 2024 $1.43M
Total Liabilities Q3 2025 · Sep 30, 2025 $804.28K
Total Liabilities Q3 2025 · Dec 31, 2024 $1.43M
Current Assets Q3 2025 · Sep 30, 2025 $598.22K
Current Assets Q3 2025 · Dec 31, 2024 $75.6K
Total Assets Q3 2025 · Sep 30, 2025 $16.53M
Total Assets Q3 2025 · Dec 31, 2024 $15.37M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.69
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.16
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$1.14
Eps Diluted restated Q3 2025 · Sep 30, 2024 −$4.28
Eps Basic Q3 2025 · Sep 30, 2025 −$0.69
Eps Basic Q3 2025 · Sep 30, 2025 −$2.16
Eps Basic restated Q3 2025 · Sep 30, 2024 −$1.14
Eps Basic restated Q3 2025 · Sep 30, 2024 −$4.28
Sga Expense Q3 2025 · Sep 30, 2025 $311.38K
Sga Expense Q3 2025 · Sep 30, 2025 $3.1M
Sga Expense Q3 2025 · Sep 30, 2024 $523.86K
Sga Expense Q3 2025 · Sep 30, 2024 $2.15M
Net Income Q3 2025 · Sep 30, 2025 −$7.62M
Net Income Q3 2025 · Sep 30, 2025 −$17.87M
Net Income Q3 2025 · Sep 30, 2024 −$2M
Net Income Q3 2025 · Sep 30, 2024 −$6.76M
Operating Income Q3 2025 · Sep 30, 2025 −$7.54M
Operating Income Q3 2025 · Sep 30, 2025 −$17.66M
Operating Income Q3 2025 · Sep 30, 2024 −$1.76M
Operating Income Q3 2025 · Sep 30, 2024 −$6.29M
Gross Profit Q3 2025 · Sep 30, 2025 $50.9K
Gross Profit Q3 2025 · Sep 30, 2025 $202.91K
Gross Profit Q3 2025 · Sep 30, 2024 $82.67K
Gross Profit Q3 2025 · Sep 30, 2024 $299.86K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $2.36K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $45.91K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $21.51K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $71.97K
Revenue Q3 2025 · Sep 30, 2025 $84.25K
Revenue Q3 2025 · Sep 30, 2025 $361.66K
Revenue Q3 2025 · Sep 30, 2024 $133.37K
Revenue Q3 2025 · Sep 30, 2024 $510.63K